Home » Clinical Trials » Arrhythmia
Clinical Trial Details
Research Study Summary
A clinical trial to evaluate treatments using Medtronic REVEAL for patients with Refractory Epilepsy, Arrhythmia or Sudden Death
Research Study Title
Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
People with epilepsy are at a higher risk for sudden unexpected death than the general
population. Sudden unexpected death in epilepsy (SUDEP) is a major cause of death in this
population, accounting for 10-50% of deaths for those with epilepsy. The risk for SUDEP is
particularly high for those with refractory epilepsy. Several lines of evidence support a
cardiac mechanism for SUDEP.
This study plans to determine:
the frequency and types of cardiac arrhythmias that occur in this population and
whether these are increased above the general population in the same age group.
Additionally, these data will be correlated to specific clinical data, including seizure
history, anticonvulsant medications, and any accompanying clinical symptoms.
To Learn more
Both Male and Female
Both Male and Female ages 16 Years to 49 Years
- Other pre-existing heart conditions
Site Locations (1)
||Thomas Jefferson University
Megan Morales, BA
Maromi Nei, MD
NCT ID: NCT00203333
Date Last Changed: November 5, 2014
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.